Fibroblast levels are increased in chronic rhinosinusitis with nasal polyps and are associated with worse subjective disease severity

International Forum of Allergy and Rhinology

Volumn 6, Issue 2, 2016, Pages 162-168

  Carroll, William W ^a   O'Connell, Brendan P ^a   Schlosser, Rodney J ^a,b   Gudis, David A ^a   Karnezis, Tom T ^a   Lawrence, Lauren A ^a   Soler, Zachary M ^a   Mulligan, Jennifer K ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b RALPH H JOHNSON VA MEDICAL CENTER   (United States)

Author keywords

Chronic rhinosinusitis; Endoscopic sinus surgery; Quality of life; Sinusitis; SNOT 22

Indexed keywords

BINDING PROTEIN; FIBROBLAST SPECIFIC PROTEIN; MUCIN 1; UNCLASSIFIED DRUG; CALCIUM BINDING PROTEIN; FSP1 PROTEIN, HUMAN;

ADULT; ALLERGIC FUNGAL RHINOSINUSITIS; ARTICLE; ASTHMA; ATOPY; CELL POPULATION; CHRONIC RHINOSINUSITIS; CONTROLLED STUDY; DISEASE SEVERITY; ENDOSCOPIC SINUS SURGERY; EX VIVO STUDY; FEMALE; FIBROBLAST; FUNGAL SINUSITIS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NASAL BIOPSY; NOSE POLYP; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; SINO NASAL OUTCOME TEST 22; ADOLESCENT; AGED; CELL SEPARATION; CHILD; CHRONIC DISEASE; DISEASE COURSE; ENDOSCOPY; METABOLISM; NASAL POLYPS; PATHOLOGY; PHYSIOLOGY; RHINITIS; SINUSITIS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CALCIUM-BINDING PROTEINS; CELL SEPARATION; CHILD; CHRONIC DISEASE; DISEASE PROGRESSION; ENDOSCOPY; FEMALE; FIBROBLASTS; HUMANS; MALE; MIDDLE AGED; NASAL POLYPS; QUALITY OF LIFE; RHINITIS; SINUSITIS; SURVEYS AND QUESTIONNAIRES; YOUNG ADULT;

EID: 84957848663     PISSN: 20426976     EISSN: 20426984     Source Type: Journal    
DOI: 10.1002/alr.21636     Document Type: Article

References (60)

1. Schiller JS, Lucas JW, Ward BW, Peregoy JA. Summary health statistics for U.S. adults: National Health Interview Survey, 2010. Vital Health Stat 10. 2012(252):1-207.
2. Van Zele T, Claeys S, Gevaert P, et al. Differentiation of chronic sinus diseases by measurement of inflammatory mediators. Allergy. 2006;61:1280-1289.
3. Carney AS, Tan LW, Adams D, Varelias A, Ooi EH, Wormald PJ. Th2 immunological inflammation in allergic fungal sinusitis, nonallergic eosinophilic fungal sinusitis, and chronic rhinosinusitis. Am J Rhinol. 2006;20:145-149.
4. Katzenstein AL, Sale SR, Greenberger PA. Pathologic findings in allergic aspergillus sinusitis. A newly recognized form of sinusitis. Am J Surg Pathol. 1983;7:439-443.
5. DeYoung K, Wentzel JL, Schlosser RJ, Nguyen SA, Soler ZM. Systematic review of immunotherapy for chronic rhinosinusitis. Am J Rhinol Allergy. 2014;28:145-150.
6. Plonk DP, Luong A. Current understanding of allergic fungal rhinosinusitis and treatment implications. Curr Opin Otolaryngol Head Neck Surg. 2014;22:221-226.
7. Thahim K, Jawaid MA, Marfani MS. Presentation and management of allergic fungal sinusitis. J Coll Physicians Surg Pak. 2007;17:23-27.
8. Philpott CM, Thamboo A, Lai L, et al. Olfactory dysfunction in allergic fungal rhinosinusitis. Arch Otolaryngol Head Neck Surg. 2011;137:694-697.
9. Al-Muhsen S, Johnson JR, Hamid Q. Remodeling in asthma. J Allergy Clin Immunol. 2011;128:451-462; quiz 463-464.
10. Van Bruaene N, Bachert C. Tissue remodeling in chronic rhinosinusitis. Curr Opin Allergy Clin Immunol. 2011;11:8-11.
11. Sheppard MN, Harrison NK. New perspectives on basic mechanisms in lung disease. 1. Lung injury, inflammatory mediators, and fibroblast activation in fibrosing alveolitis. Thorax. 1992;47:1064-1074.
12. Page CP, Banner KH, Spina D. Cellular Mechanisms in Airways Inflammation. Basel: Birkhäuser Verlag; 2000.
13. Roche WR, Beasley R, Williams JH, Holgate ST. Subepithelial fibrosis in the bronchi of asthmatics. Lancet. 1989;333:520-524.
14. Lazaar AL, Panettieri RA Jr. Is airway remodeling clinically relevant in asthma? Am J Med. 2003;115:652-659.
15. Laprise C, Laviolette M, Boutet M, Boulet LP. Asymptomatic airway hyperresponsiveness: relationships with airway inflammation and remodelling. Eur Respir J. 1999;14:63-73.
16. Chetta A, Foresi A, Del Donno M, Bertorelli G, Pesci A, Olivieri D. Airways remodeling is a distinctive feature of asthma and is related to severity of disease. Chest. 1997;111:852-857.
17. Kouzaki H, Seno S, Fukui J, Owaki S, Shimizu T. Role of platelet-derived growth factor in airway remodeling in rhinosinusitis. Am J Rhinol Allergy. 2009;23:273-280.
18. Nonaka M, Ogihara N, Fukumoto A, Sakanushi A, Pawankar R, Yagi T. Toll-like receptor 2, 3, 4, 5 ligands and interleukin-4 synergistically induce TARC production in nasal polyp fibroblasts. Auris Nasus Larynx. 2008;35:515-520.
19. Maune S, Berner I, Sticherling M, Kulke R, Bartels J, Schröder JM. Fibroblasts but not epithelial cells obtained from human nasal mucosa produce the chemokine RANTES. Rhinology. 1996;34:210-214.
20. Yoshifuku K, Matsune S, Ohori J, Sagara Y, Fukuiwa T, Kurono Y. IL-4 and TNF-alpha increased the secretion of eotaxin from cultured fibroblasts of nasal polyps with eosinophil infiltration. Rhinology. 2007;45:235-241.
21. Oyer SL, Mulligan JK, Psaltis AJ, Henriquez OA, Schlosser RJ. Cytokine correlation between sinus tissue and nasal secretions among chronic rhinosinusitis and controls. Laryngoscope. 2013;123:E72-E78.
22. Fukuda K, Nishida T, Fukushima A. Synergistic induction of eotaxin and VCAM-1 expression in human corneal fibroblasts by staphylococcal peptidoglycan and either IL-4 or IL-13. Allergol Int. 2011;60:355-363.
23. Homma H, Kamiya K, Kusunoki T, Ikeda K. Multiplex analyses of cytokine and chemokine release from the cultured fibroblast of nasal polyps: the effect of IL-17A. Acta Otolaryngol. 2013;133:1065-1072.
24. Molet SM, Hamid QA, Hamilos DL. IL-11 and IL-17 expression in nasal polyps: relationship to collagen deposition and suppression by intranasal fluticasone propionate. Laryngoscope. 2003;113:1803-1812.
25. Frieri M. Asthma linked with rhinosinusitis: an extensive review. Allergy Rhinol (Providence). 2014;5:41-49.
26. Oyer SL, Nagel W, Mulligan JK. Differential expression of adhesion molecules by sinonasal fibroblasts among control and chronic rhinosinusitis patients. Am J Rhinol Allergy. 2013;27:381-386.
27. Fokkens W, Lund V, Mullol J. European Position Paper on Rhinosinusitis and Nasal Polyps Group. EP3OS 2007: European position paper on rhinosinusitis and nasal polyps 2007. A summary for otorhinolaryngologists. Rhinology. 2007;45:97-101.
28. Bent JP 3rd, Kuhn FA. Diagnosis of allergic fungal sinusitis. Otolaryngol Head Neck Surg. 1994;111:580-588.
29. Bent JP 3rd, Kuhn FA. Allergic fungal sinusitis/polyposis. Allergy Asthma Proc. 1996;17:259-268.
30. Mulligan JK, Nagel W, O'Connell BP, Wentzel J, Atkinson C, Schlosser RJ. Cigarette smoke exposure is associated with vitamin D3 deficiencies in patients with chronic rhinosinusitis. J Allergy Clin Immunol. 2014;134:342-349.
31. Wong LS, Green HM, Feugate JE, Yadav M, Nothnagel EA, Martins-Green M. Effects of "second-hand" smoke on structure and function of fibroblasts, cells that are critical for tissue repair and remodeling. BMC Cell Biol. 2004;5:13.
32. Rennard SI, Togo S, Holz O. Cigarette smoke inhibits alveolar repair: a mechanism for the development of emphysema. Proc Am Thorac Soc. 2006;3:703-708.
33. Psaltis AJ, Schlosser RJ, Yawn JR, Henriquez O, Mulligan JK. Characterization of B-cell subpopulations in patients with chronic rhinosinusitis. Int Forum Allergy Rhinol. 2013;3:621-629.
34. Mulligan JK, Bleier BS, O'Connell B, Mulligan RM, Wagner C, Schlosser RJ. Vitamin D3 correlates inversely with systemic dendritic cell numbers and bone erosion in chronic rhinosinusitis with nasal polyps and allergic fungal rhinosinusitis. Clin Exp Immunol. 2011;164:312-320.
35. Mulligan JK, Mulligan RM, Atkinson C, Schlosser RJ. Human sinonasal epithelial cells direct dendritic function and T-cell T helper 1/T helper 2 skewing following Aspergillus exposure. Int Forum Allergy Rhinol. 2011;1:268-274.
36. Hopkins C, Gillett S, Slack R, Lund VJ, Browne JP. Psychometric validity of the 22-item Sinonasal Outcome Test. Clin Otolaryngol. 2009;34:447-454.
37. Piccirillo JF, Merritt MG Jr., Richards ML. Psychometric and clinimetric validity of the 20-Item Sino-Nasal Outcome Test (SNOT-20). Otolaryngol Head Neck Surg. 2002;126:41-47.
38. Hamilos DL. Chronic rhinosinusitis patterns of illness. Clin Allergy Immunol. 2007;20:1-13.
39. Shaw JL, Ashoori F, Fakhri S, Citardi MJ, Luong A. Increased percentage of mast cells within sinonasal mucosa of chronic rhinosinusitis with nasal polyp patients independent of atopy. Int Forum Allergy Rhinol. 2012;2:233-240.
40. Pearlman AN, Chandra RK, Chang D, et al., Relationships between severity of chronic rhinosinusitis and nasal polyposis, asthma, and atopy. Am J Rhinol Allergy. 2009;23:145-148.
41. Krouse JH. Computed tomography stage, allergy testing, and quality of life in patients with sinusitis. Otolaryngol Head Neck Surg. 2000;123:389-392.
42. Peters AT, Kato A, Zhang N, et al. Evidence for altered activity of the IL-6 pathway in chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol. 2010;125:397-403.e10.
43. Basu S, Georgalas C, Kumar BN, Desai S. Correlation between symptoms and radiological findings in patients with chronic rhinosinusitis: an evaluation study using the Sinonasal Assessment Questionnaire and Lund-Mackay grading system. Eur Arch Otorhinolaryngol. 2005;262:751-754.
44. Stewart MG, Sicard MW, Piccirillo JF, Diaz-Marchan PJ. Severity staging in chronic sinusitis: are CT scan findings related to patient symptoms? Am J Rhinol. 1999;13:161-167.
45. Smith TL, Rhee JS, Loehrl TA, Burzynski ML, Laud PW, Nattinger AB. Objective testing and quality-of-life evaluation in surgical candidates with chronic rhinosinusitis. Am J Rhinol. 2003;17:351-356.
46. Morantz RA, Walsh JW. Brain Tumors: A Comprehensive Text. New York: Marcel Dekker, Inc.; 1994. Neurological Disease and Therapy. Vol. 20.
47. Kaye AH, Laws ER. Brain Tumors: An Encyclopedic Approach. Edinburgh: Churchill Livingstone 1995.
48. Schlosser RJ, Wilensky EM, Grady MS, Bolger WE. Elevated intracranial pressures in spontaneous cerebrospinal fluid leaks. Am J Rhinol. 2003;17:191-195.
49. Woodworth BA, Prince A, Chiu AG, et al. Spontaneous CSF leaks: a paradigm for definitive repair and management of intracranial hypertension. Otolaryngol Head Neck Surg. 2008;138:715-720.
50. Kirtane MV, Gautham K, Upadhyaya SR. Endoscopic CSF rhinorrhea closure: our experience in 267 cases. Otolaryngol Head Neck Surg. 2005;132:208-212.
51. Carey MA, Card JW, Voltz JW, et al. It's all about sex: gender, lung development and lung disease. Trends Endocrinol Metab. 2007;18:308-313.
52. Lekgabe ED, Royce SG, Hewitson TD, et al. The effects of relaxin and estrogen deficiency on collagen deposition and hypertrophy of nonreproductive organs. Endocrinology. 2006;147:5575-5583.
53. Card JW, Voltz JW, Ferguson CD, et al. Male sex hormones promote vagally mediated reflex airway responsiveness to cholinergic stimulation. Am J Physiol Lung Cell Mol Physiol. 2007;292:L908-L914.
54. Corteling R, Trifilieff A. Gender comparison in a murine model of allergen-driven airway inflammation and the response to budesonide treatment. BMC Pharmacol. 2004;4:4.
55. Matsubara S, Swasey CH, Loader JE, et al. Estrogen determines sex differences in airway responsiveness after allergen exposure. Am J Respir Cell Mol Biol. 2008;38:501-508.
56. Sabatini F, Petecchia L, Usai C, et al. Pharmacological modulation of the bradykinin-induced differentiation of human lung fibroblasts: effects of budesonide and formoterol. J Asthma. 2012;49:1004-1011.
57. Rostkowska-Nadolska B, Fraczek M, Gawron W, Latocha M. Influence of vitamin D(3) analogues in combination with budesonid R on proliferation of nasal polyp fibroblasts. Acta Biochim Pol. 2009;56:235-242.
58. Shin HW, Cho K, Kim DW, et al. Hypoxia-inducible factor 1 mediates nasal polypogenesis by inducing epithelial-to-mesenchymal transition. Am J Respir Crit Care Med. 2012;185:944-954.
59. Hupin C, Gohy S, Bouzin C, Lecocq M, Polette M, Pilette C. Features of mesenchymal transition in the airway epithelium from chronic rhinosinusitis. Allergy. 2014;69:1540-1549.
60. Hirano S, Asano K, Namba M, Kanai K, Hisamitsu T, Suzaki H. Induction of apoptosis in nasal polyp fibroblasts by glucocorticoids in vitro. Acta Otolaryngol. 2003;123:1075-1079.